Company logo

RDNT - RadNet, Inc.

NASDAQ -> Healthcare -> Diagnostics & Research
Los Angeles, United States
Type: Equity

RDNT price evolution
RDNT
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jul 2023 31 Mar 2023
Current assets
Cash $342.57 $337.88 $356.65 $90.84
Short term investments
Net receivables $189.05 $192.58 $196.72 $196.74
Inventory
Total current assets $579.28 $578.67 $602.69 $342.69
Long term investments $92.71 $94.47 $52.49 $59.32
Property, plant & equipment $1200.43 $1190.39 $1203.22 $1168.8
Goodwill & intangible assets $770.08 $768.21 $788.31 $790.09
Total noncurrent assets $2111.2 $2109.35 $2102.6 $2071.38
Total investments $92.71 $94.47 $52.49 $59.32
Total assets $2690.47 $2688.03 $2705.29 $2414.07
Current liabilities
Accounts payable $358.85 $326.53 $353.69 $328.27
Deferred revenue $4.65 $5.18 $5.05 $4.34
Short long term debt $73.95 $75.37 $75.49 $74.53
Total current liabilities $437.45 $407.08 $434.23 $407.14
Long term debt $1417.16 $1458.34 $1477.18 $1475.89
Total noncurrent liabilities $1439.66 $1484.79 $1510.05 $1513.83
Total debt $1491.12 $1533.71 $1552.67 $1550.42
Total liabilities $1877.11 $1891.87 $1944.29 $1920.97
Shareholders' equity
Retained earnings -$79.58 -$77.72 -$95.26 -$103.63
Other shareholder equity -$12.48 -$18.3 -$15.18 -$16.98
Total shareholder equity $630.7 $618.9 $593.16 $327.92
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $342.57 $127.83 $134.61 $102.02
Short term investments
Net receivables $189.05 $185.33 $140.45 $135.42
Inventory
Total current assets $579.28 $367.18 $324.26 $270.42
Long term investments $92.71 $57.89 $42.23 $34.53
Property, plant & equipment $1200.43 $1169.48 $1068.54 $883
Goodwill & intangible assets $770.08 $783.89 $570.42 $525.27
Total noncurrent assets $2111.2 $2066.72 $1734.21 $1516.23
Total investments $92.71 $57.89 $42.23 $34.53
Total assets $2690.47 $2433.91 $2058.47 $1786.66
Current liabilities
Accounts payable $358.85 $125.78 $287.47 $250.69
Deferred revenue $4.65 $4.02 $10.7 $39.26
Short long term debt $73.95 $70.01 $76.62 $108.16
Total current liabilities $437.45 $466.72 $374.78 $398.11
Long term debt $1417.16 $839.34 $1321.17 $1076.75
Total noncurrent liabilities $1439.66 $1475.73 $1337.53 $1130.24
Total debt $1491.12 $1513.47 $1397.79 $1184.91
Total liabilities $1877.11 $2100.91 $1712.32 $1528.35
Shareholders' equity
Retained earnings -$79.58 -$82.62 -$93.27 -$118
Other shareholder equity -$12.48 -$20.68 -$20.42 -$24.05
Total shareholder equity $630.7 $333 $228.9 $165.74
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jul 2023 31 Mar 2023
Revenue
Total revenue $420.38 $401.97 $390.56
Cost of revenue $356.59 $341.63 $351.87
Gross Profit $63.79 $60.33 $38.7
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $34.31 $33.89 $32.03
Operating income $29.48 $26.44 $6.67
Income from continuing operations
EBIT $15.48 $40.88 -$4.15
Income tax expense $0.73 $7.22 $1.14
Interest expense $16.61 $16.11 $15.72
Net income
Net income -$1.86 $17.54 -$21
Income (for common shares) -$1.86 $17.54 -$21
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $1616.63 $1430.06 $1315.08 $1071.84
Cost of revenue $1395.24 $1264.35 $1123.27 $965.9
Gross Profit $221.39 $165.72 $191.8 $105.94
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $134.36 $119.35 $89.57 $70.25
Operating income $87.03 $46.36 $102.23 $35.68
Income from continuing operations
EBIT $76 $70.85 $88.12 $31.94
Income tax expense $8.47 $9.36 $14.56 $0.9
Interest expense $64.48 $50.84 $48.83 $45.88
Net income
Net income $3.04 $10.65 $24.73 -$14.84
Income (for common shares) $3.04 $10.65 $24.73 -$14.84
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$1.86 $17.54 $8.37 -$21
Operating activities
Depreciation $46.25 $48.15 $48.08 $47.01
Business acquisitions & disposals -$8.59 -$5.76 -$0.96 -$9.64
Stock-based compensation $5.41 $4.33 $4.87 $12.19
Total cash flows from operations $88.92 $31.25 $68.08 $32.62
Investing activities
Capital expenditures -$40.06 -$41.15 -$39.4 -$55.91
Investments
Total cash flows from investing -$48.65 -$46.91 -$40.35 -$65.56
Financing activities
Dividends paid
Sale and purchase of stock $0.07 -$0.35 $246.2 $0.05
Net borrowings -$31 -$4.56 -$4.56 -$3.87
Total cash flows from financing -$35.47 -$3.2 $238.12 -$3.82
Effect of exchange rate -$0.12 $0.1 -$0.04 -$0.23
Change in cash and equivalents $4.69 -$18.77 $265.81 -$36.99
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $3.04 $10.65 $24.73 -$14.84
Operating activities
Depreciation $189.49 $184.72 $170.66 $154.71
Business acquisitions & disposals -$24.95 -$1.44 -$1.44 -$1.64
Stock-based compensation $26.79 $23.77 $25.2 $12.4
Total cash flows from operations $220.86 $146.42 $149.49 $233.76
Investing activities
Capital expenditures -$176.52 -$115.55 -$214.94 -$124.61
Investments
Total cash flows from investing -$201.47 -$246.95 -$221.51 -$126.24
Financing activities
Dividends paid
Sale and purchase of stock $245.97 $0.29 $0.49
Net borrowings -$43.99 $94.25 $93.54 -$43.58
Total cash flows from financing $195.63 $93.65 $104.67 -$45.56
Effect of exchange rate -$0.29 $0.11 -$0.07 -$0.1
Change in cash and equivalents $214.74 -$6.77 $32.59 $61.85
Fundamentals
Market cap $3.30B
Enterprise value $4.44B
Shares outstanding 67.96M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q 9.51%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 5.12
Book/Share 9.46
Cash/Share 5.04
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 2.98
Net debt/EBITDA N/A
Current ratio 1.32
Quick ratio 1.32